Hypoplastic left heart syndrome as a manifestation of a special form of the Werdnig-Hoffmann disease;Hypoplastisch linkerhartsyndroom als uiting van een bijzondere vorm van de ziekte van Werdnig-Hoffmann

Tijdschrift voor Kindergeneeskunde

Volumn 74, Issue 5, 2006, Pages 184-188

  Menke, L A ^a   Poll The, B T ^a   Rozemuller, J M ^b   LoaNjoe, S M ^a   Lemmink, H H ^c   Cobben, J M ^a  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASPHYXIA; AUTOPSY; CASE REPORT; CLINICAL FEATURE; CONGENITAL HEART MALFORMATION; HEREDITY; HOMOZYGOSITY; HUMAN; MEDICAL LITERATURE; NEWBORN; PEDIATRICIAN; WERDNIG HOFFMANN DISEASE;

EID: 33750213954     PISSN: 03767442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Roberts D, Chavez J, Court S. The genetic component in child mortality. Arch Dis Child 1970;45:33-8.
2. Pearn J. Incidence, prevalence and gene frequency studies of chronic childhood spinal muscular atrophy. J Med Genet 1978;15:409-13.
3. Munsat T, Davies K. International SMA consortium meeting (26-28 June 1992, Bonn, Germany). Neuromuscul Disord 1992;2:423-8.
4. Iannaccone S, Browne R, Samaha F, et al. Prospective study of spinal muscular atrophy before age 6 years. Pediatr Neurol 1993;9:187-93.
5. Zerres K. Rudnik-Schoneborn S. Natural history in proximal spinal muscular atrophy. Arch Neurol 1995;52:518-23.
6. Nicole S, Diaz C, Frugier T, et al. Spinal muscular atrophy: recent advances and future prospects. Muscle Nerve 2002;26:4-13.
7. Lefebvre S, Burglen L, Reboullet S, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 1995;80:155-65.
8. Engel W. Selective and non-selective susceptibility for muscle fiber types. Arch Neurol 1970;22:97-117.
9. Matthijs G, Devriendt K, Fryns J. The prenatal diagnosis of spinal muscular atrophy. Prenat Diagn 1998;18:607-10.
10. Rudnik-Schoneborn S, Forkert R, Hahnen E, et al. Clinical spectrum and diagnostic criteria of infantile spinal muscular atrophy: further delineation on the basis of SMN gene deletion findings. Neuropediatrics 1996;27:8-15.
11. Moller P, Moe N, Saugstad O, et al. Spinal muscular atrophy type I combined with atrial septal defect in three children. Clin Genet 1990;38:81-3.
12. Devriendt K, Lammens M, Schollen E, et al. Clinical and molecular genetic features of congenital spinal muscular atrophy. Ann Neurol 1996;40:731-8.
13. Munsat TL Workshop report - International SMA collaboration. Neuromuscul Disord 1991;1:81.
14. Burglen L, Spiegel R, Ignatius E, et al. SMN gene deletion in variant of infantile spinal muscular atrophy. Lancet 1995;346(8970):316-7.
15. Mulleners W, Ravenswaay C van, Gabreëls F, et al. Spinal muscular atrophy combined with congenital heart disease: a report of two cases. Neuropediatrics 1996;27:333-4.
16. Jong Y, Chang J, Wu J. Large scale deletions in a Chinese infant associated with a variant form of Werdnig-Hoffmann disease. Neurology 1998;51(3):878-9.
17. El-Matary E, Kotagiri S, Cameron D, et al. Spinal muscular atrophy type I (Werdnig-Hoffman disease) with complex cardiac malformation. Eur J Fed 2004;163:331-2.